Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA Internal Medicine"
DOI: 10.1001/jamainternmed.2022.0502
Abstract: Key Points Question Can increasing awareness about deprescribing prior to primary care visits reduce the use of potentially inappropriate long-term medications for individuals with cognitive impairment? Findings In this pragmatic cluster randomized clinical trial of… read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2019.10319
Abstract: Key Points Question Is alcohol consumption associated with the risk of dementia and cognitive decline in older adults with or without mild cognitive impairment? Findings In this cohort study of 3021 participants aged 72 years… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2019.13383
Abstract: Key Points Question Is β-amyloid deposition in the brain associated with sleep dysfunction and cognition in elderly individuals with cognitive disorders? Findings In this survey study of 52 participants aged 65 years and older, β-amyloid… read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2019.3016
Abstract: This cluster randomized, multicomponent comparative effectiveness trial compares the incremental effects of combinations of 5 behavioral interventions on outcomes of highest importance to patients with mild cognitive impairment. read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2020.5719
Abstract: Key Points Question Are modifiable lifestyle factors associated with cortical amyloid burden or cerebral glucose metabolism in older adults with mild cognitive impairment? Findings This cohort study included 118 older adults with mild cognitive impairment… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.20680
Abstract: Key Points Question Is initiation of angiotensin II receptor blockers (ARBs), compared with angiotensin-converting enzyme inhibitors (ACEIs), associated with a reduced risk of cognitive impairment, after controlling for potential pretreatment confounders? Findings This active-comparator, new-user… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2024.19640
Abstract: Key Points Question Among older adults (aged 60 years or older) hospitalized for COVID-19, is in-hospital delirium associated with functional disability and cognitive impairment over the 6 months after discharge? Findings In this cohort study… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2024.53756
Abstract: Key Points Question Can the age at onset of mild cognitive impairment (MCI) and Alzheimer dementia (AD) be predicted using a statistical modeling approach? Findings In this prognostic study that used data from 3787 patients,… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "JAMA neurology"
DOI: 10.1001/jamaneurol.2020.3921
Abstract: Importance Tau accumulation in Alzheimer disease (AD) is closely associated with cognitive impairment. Quantitating tau accumulation by positron emission tomography (PET) will be a useful outcome measure for future clinical trials in the AD spectrum.… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA neurology"
DOI: 10.1001/jamaneurol.2022.2379
Abstract: Importance National Institute on Aging-Alzheimer's Association (NIA-AA) workgroups have proposed biological research criteria intended to identify individuals with preclinical Alzheimer disease (AD). Objective To assess the clinical value of these biological criteria to identify older… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA Neurology"
DOI: 10.1001/jamaneurol.2022.3157
Abstract: Key Points Question Do amyloid positron emission tomography (PET) positivity rates differ across racial and ethnic groups with mild cognitive impairment (MCI) or dementia? Findings In this cohort study of 17 107 Medicare beneficiaries with MCI… read more here.